Thursday, 15 October 2026
Breakthrough pancreatic cancer drug doubles survival in late-stage patients
Stress Checks

Breakthrough pancreatic cancer drug doubles survival in late-stage patients

FDA-approved daraxonrasib may double survival for late-stage pancreatic cancer patients after chemotherapy failure, per University of Chicago trial data.

By Lyra Ashworth  •  01/10/2026
FDA approves Mounjaro for diabetes heart risk reduction
Stress Checks

FDA approves Mounjaro for diabetes heart risk reduction

FDA approves Mounjaro for diabetes to reduce heart risks in adults. This new approval lowers risks of major adverse cardiovascular…

By Lyra Ashworth  •  01/09/2026
FDA clears new drug for rare skin condition
Drug Doses

FDA clears new drug for rare skin condition

The FDA approved Lisraya (brepocitinib) for dermatomyositis, a rare skin condition causing inflammation and muscle weakness, offering targeted treatment.

By Ember Pennington  •  28/08/2026